Bile Acid CAS Numbers and Naming: Order the Right One
Share
Few product families punish loose naming like the bile acids. The molecules are close relatives, the abbreviations overlap, and three languages of naming sit on every commercial document. A purchase order that says only "UDCA 98%" is usually fine. A purchase order that says "7-keto" anything deserves a second look, because that is the corner of the family where one wrong digit buys a different substance.
The fix is not memorising the family. It is one discipline: the CAS registry number is the anchor, and everything else is a label that must agree with it.
Why names collide
Three mechanisms generate the confusion. Abbreviation habits differ: some markets write UDCA for the free acid, others reach for the same letters when they mean a conjugate, and TUDCA versus UDCA is a taurine group, not a typo, a difference unpacked in the TUDCA and UDCA comparison. Translation layers stack: a Chinese document, a Latin pharmacopoeial name and an English trade name can describe one substance correctly while looking unrelated. And close relatives differ by a single functional group: CDCA and UDCA differ at one hydroxyl position, and 7-KLCA is the oxidised form of the same skeleton, which is why the 7-keto intermediate sits at the centre of both UDCA and OCA synthesis routes, as mapped in the 7-KLCA intermediate piece.
The family as a whole is laid out in the bile acid family reference map, which is the fastest cure for guesswork. But a map only helps if documents carry coordinates, and the coordinate that survives every translation is the registry number maintained by CAS.
The three-line discipline
Specify every bile acid on three lines, and require the same of any supplier document you accept.
Line one: the registry number. Written in full, checked against an independent database rather than copied from the counterparty's paper. Public registries such as PubChem resolve a CAS number to a structure in seconds, which is the whole point.
Line two: the unambiguous name. Use the pharmacopoeial or systematic name in full, not the abbreviation. Where stereochemistry matters, and in this family it always does, the full name carries it; abbreviations do not. The epimer question is not academic, as the piece on chiral purity and epimers shows with real analytical consequences.
Line three: the form. Free acid or salt, anhydrous or hydrate, and purity basis. Two of the three lines can be perfect and the third can still change what you receive.
Anything that fails one of the three lines is a question, not an order. Suppliers who know their own chemistry answer instantly; suppliers who hesitate have told you something useful.
What the discipline catches
Three recurring near-misses. Conjugate confusion, where a buyer means the free acid and receives a taurine or glycine conjugate, or the reverse. Epimer confusion, where hyodeoxycholic and ursodeoxycholic materials are cross-quoted because abbreviations collide. And form confusion, where a quote at a lower price is simply a different salt or moisture basis, a pricing phenomenon analysed in why quotes for the same specification differ.
None of these requires chemistry knowledge to prevent. They require a document habit: number first, full name second, form third. The IUPAC naming system exists so that chemistry has one address per molecule; commercial documents that use it are simply harder to get wrong.
Naming, done this way, is the cheapest quality control in the supply chain. It costs one line on a purchase order and prevents the one mistake that no downstream test can cheaply undo: receiving the wrong molecule, correctly certified.
A working reference table for the family's most-traded members shows why the discipline earns its keep. Every row is one steroid skeleton with a different oxidation or conjugation state; every row has its own registry number; and every row has at least one abbreviation that collides with a neighbour's.
| Substance | What distinguishes it | Common confusion |
|---|---|---|
| Ursodeoxycholic acid | Free acid, 7-beta hydroxyl | Abbreviation collision with conjugates |
| Chenodeoxycholic acid | Free acid, 7-alpha hydroxyl | Same skeleton, different epimer |
| 7-Ketolithocholic acid | Oxidised at 7-position | Quoted as both a product and an impurity |
| Tauroursodeoxycholic acid | Taurine conjugate of UDCA | One letter from UDCA in abbreviated form |
The epimer row is where analytical consequences live. Two substances differing at one stereocentre are different molecules with different pharmacology and different chromatographic behaviour, and a specification that does not state stereochemistry explicitly has left the definition to the reader. The measurement side is treated in the epimers and chiral purity piece.
Verification of the number is a two-minute habit. Independent public registries, including PubChem, resolve a registry number to a structure, which catches both honest transcription errors and the rarer case of a document citing a number that belongs to a different substance entirely. The registry system itself is maintained by CAS, and the systematic naming behind the full names is governed by IUPAC conventions.
One vendor-side caution closes the piece: catalogue names are marketing objects. They shorten, they brand, and they occasionally attach a family name to a salt or a blend. The three-line discipline exists precisely so that what arrives is decided by the document, not by the catalogue, and so that the certificate of analysis that comes back describes the same molecule the purchase order asked for.
Frequently asked questions
Why insist on CAS numbers in purchase orders?
Because names drift across languages, abbreviations and vendors, while a registry number resolves to exactly one structure. Checking it against an independent database takes seconds and prevents the costliest ordering error: receiving a different molecule, correctly documented.
How do TUDCA and UDCA get confused?
Both are four-letter abbreviations that differ by one letter, but the difference is a whole taurine conjugate. They are different substances with different uses, and the free-acid-versus-conjugate distinction must be stated explicitly, never inferred from the abbreviation.
What are the three lines of an unambiguous bile acid specification?
The CAS registry number verified against an independent database; the full pharmacopoeial or systematic name rather than an abbreviation; and the form, meaning free acid or salt, anhydrous or hydrate, and the purity basis.
Where does the family collide most often?
Around the 7-position: CDCA, UDCA and 7-ketolithocholic acid share one steroid skeleton and differ by a single functional group. The 7-keto intermediate is central to several synthesis routes, which is why it appears in quotes for very different end uses.
Can a COA with the wrong substance still look correct?
Yes, and that is the danger. A COA is internally consistent for whatever it tested. If the wrong molecule was shipped, every number on the paper can be genuine and the shipment still wrong, which is why naming is controlled before testing, not after.
Do suppliers mind being asked for CAS numbers?
No competent one does. The request signals a buyer who verifies, and any hesitation to state a registry number is itself information worth having.